European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder

  1. Coghill, D.
  2. Banaschewski, T.
  3. Lecendreux, M.
  4. Soutullo, C.
  5. Johnson, M.
  6. Zuddas, A.
  7. Anderson, C.
  8. Civil, R.
  9. Higgins, N.
  10. Lyne, A.
  11. Squires, L.
Revue:
European Neuropsychopharmacology

ISSN: 0924-977X,  1873-7862

Année de publication: 2013

Volumen: 23

Número: 10

Pages: 1208-1218

Type: Article

DOI: 10.1016/J.EURONEURO.2012.11.012 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus